2022
DOI: 10.1016/j.crgsc.2022.100303
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis of selenium nanoparticles using combinations of plant extracts and their antibacterial activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(5 citation statements)
references
References 64 publications
0
5
0
Order By: Relevance
“…As previously depicted, phytosynthesized SeNPs (diameter of 23.2 nm) coated by chitosan (20 μg ml −1 ) could inhibit L. monocytogenes with zone diameter of 17.2 mm in diffusion test [69], while bio-SeNPs (particle diameter of 50-200 nm) synthesized by Moringa oleifera extract at the concentration of 700 μg ml −1 displayed an inhibitory diameter of 14.7 mm [70]. However, for E. coli species, while some works reported on E. coli inhibition at SeNP concentrations of 100 μg ml −1 and 950 μg ml −1 with diameter of 9 mm and 19 mm respectively [71,72], the others described the resistance of E. coli treated with these nanoparticles [9]. In brief, in agreement with previous studies, the antibacterial activity of our SeNPs was shown against E. coli and L. monocytogenes in agar well-diffusion assay; however when compared with those reports, this activity was expressed lower (d < 12 mm).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As previously depicted, phytosynthesized SeNPs (diameter of 23.2 nm) coated by chitosan (20 μg ml −1 ) could inhibit L. monocytogenes with zone diameter of 17.2 mm in diffusion test [69], while bio-SeNPs (particle diameter of 50-200 nm) synthesized by Moringa oleifera extract at the concentration of 700 μg ml −1 displayed an inhibitory diameter of 14.7 mm [70]. However, for E. coli species, while some works reported on E. coli inhibition at SeNP concentrations of 100 μg ml −1 and 950 μg ml −1 with diameter of 9 mm and 19 mm respectively [71,72], the others described the resistance of E. coli treated with these nanoparticles [9]. In brief, in agreement with previous studies, the antibacterial activity of our SeNPs was shown against E. coli and L. monocytogenes in agar well-diffusion assay; however when compared with those reports, this activity was expressed lower (d < 12 mm).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the antibacterial activity of SeNPs has also been reported in former studies. Particularly, SeNPs could inhibit the growth of Vibrio parahaemolyticus, Staphylococcus areus, Enterococcus faecalis, Pseudomonas aeruginosa, etc [9][10][11][12]. The increase in antibiotic resistance becomes a major challenge for clinical infection treatments, thereby posing a demand for novel antibiotic development.…”
Section: Introductionmentioning
confidence: 99%
“…The antibacterial activity of selenium compounds is attributed to the generation of free radicals, including Se oxyanions [ 501 ]. These novel active products might constitute a solution to the emerging drug-resistant microorganisms that are considered to be a great current health concern [ 62 , 502 , 503 , 504 ]. The unique antibacterial effect of biosynthesized SeNPs has been extensively explored on the basis of morphological and structural changes in the bacterial cells [ 160 , 316 , 490 , 491 , 495 ].…”
Section: Biomedical Applications Of Biogenic Selenium Nanoparticlesmentioning
confidence: 99%
“…A recent article explored the antimicrobial activity of synthesized SeNP (245-321 nm) using extract of Allium cepa, Malpighia emarginata, and Gymnanthemum amygdalinum against gram-positive resistant pathogens, like Streptococcus agalactiae, S. aureus, and MRSA. It suggested that SeNP could be a promising option in the treatment of MDR bacteria with high efficacy along with low cytotoxicity in red blood cell [52].…”
Section: Nanoparticles (Nps)mentioning
confidence: 99%